NASDAQ:NEOG • US6404911066
The current stock price of NEOG is 10.98 USD. In the past month the price increased by 11.25%. In the past year, price increased by 9.36%.
ChartMill assigns a technical rating of 9 / 10 to NEOG. When comparing the yearly performance of all stocks, NEOG is one of the better performing stocks in the market, outperforming 91.79% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to NEOG. The financial health of NEOG is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months NEOG reported a non-GAAP Earnings per Share(EPS) of 0.29. The EPS decreased by -27.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.94% | ||
| ROE | -28.64% | ||
| Debt/Equity | 0.38 |
11 analysts have analysed NEOG and the average price target is 11.22 USD. This implies a price increase of 2.19% is expected in the next year compared to the current price of 10.98.
For the next year, analysts expect an EPS growth of -9.33% and a revenue growth -4.55% for NEOG
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 31.82 | 62.678B | ||
| COO | COOPER COS INC/THE | 18.34 | 16.345B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.91 | 13.691B | ||
| SOLV | SOLVENTUM CORP | 11.37 | 12.993B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 19.83 | 4.92B | ||
| LNTH | LANTHEUS HOLDINGS INC | 12.95 | 4.845B | ||
| ICUI | ICU MEDICAL INC | 18.26 | 3.744B | ||
| HAE | HAEMONETICS CORP/MASS | 11.05 | 2.817B | ||
| XRAY | DENTSPLY SIRONA INC | 8.04 | 2.492B |
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. The company is headquartered in Lansing, Michigan and currently employs 2,974 full-time employees. The firm has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
NEOGEN CORP
620 Lesher Pl
Lansing MICHIGAN 48912 US
CEO: John E. Adent
Employees: 2917
Phone: 15173729200
Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. The company is headquartered in Lansing, Michigan and currently employs 2,974 full-time employees. The firm has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
The current stock price of NEOG is 10.98 USD. The price decreased by -1.52% in the last trading session.
NEOG does not pay a dividend.
NEOG has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
NEOGEN CORP (NEOG) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
The PE ratio for NEOGEN CORP (NEOG) is 37.86. This is based on the reported non-GAAP earnings per share of 0.29 and the current share price of 10.98 USD.
NEOGEN CORP (NEOG) has a market capitalization of 2.39B USD. This makes NEOG a Mid Cap stock.